Clinical trials: 5-FU, completed
Advanced Pancreatic Carcinoma
Study of Individualized Selection of Chemotherapy in Patients With Advanced Pancreatic Carcinoma According to Therapeutic Targets
The purpose of this study is to determine the proportion of patients alive after 12 months of the beginning of the trial in patients with advanced pancreatic carcinoma individually selected and grouped according to the expression…
- Trial name
- NCT01454180
- Testing
- gemcitabine, or gemcitabine and capecitabine, or gemcitabine and erlotinib, or FOLFIRINOX, or FOLFOX, or FOLFIRI., Gemcitabine, Gemcitabine-Capecitabine, Gemcitabine-Erlotinib, FOLFOXIRI, FOLFOX, FOLFIRI
- Where
- 2 sites in Spain
- Volunteers
- 31 people
- Sponsor
- Centro Nacional de Investigaciones Oncologicas CARLOS III
Biliary Tract Cancer
Study of Hepatic Arterial Infusion to Treat Biliary Tract Carcinomas
This Phase II clinical trial is to study the effectiveness and safety of continuous hepatic arterial infusion (HAI) of Oxaliplatin and Fluorouracil in Patients with Unresectable Biliary tract carcinomas, and to explore a better…
- Trial name
- NCT01572324
- Testing
- Oxaliplatin, Fluorouracil, Leucovorin, Capecitabine
- Where
- China
- Volunteers
- 37 people
- Sponsor
- Peking University
Actinic Keratosis
Measuring Adherence To Topical 5-Fluorouracil in a Clinic Population
The purpose of this research study is to measure adherence to the study drug (Carac) for the treatment of actinic keratoses.
- Trial name
- NCT00696488
- Testing
- Fluorouracil 0.5%
- Where
- United States
- Volunteers
- 20 people
- Sponsor
- Wake Forest University
Kidney Cancer
Interleukin-2, Interferon Alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Undergone Surgery for Kidney Cancer
RATIONALE: Interferon alfa may interfere with the growth of tumor cells. Interleukin-2 may stimulate a person's white blood cells to kill tumor cells.
- Trial name
- NCT00053807
- Testing
- aldesleukin, recombinant interferon alfa, fluorouracil
- Where
- 17 sites in Austria, Belgium and 6 more
- Volunteers
- 96 people
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
Rectal Cancer
No Operation After Short Course Radiotherapy Followed By Consolidation Chemotherapy In Locally Advanced Rectal Cancer
This study is designed to explore the hypothesis that in patients with a Locally advanced rectal cancer (LARC) treated with a Total neoadjuvant therapy (TNT) strategy based on short course radiotherapy (5x5Gy) followed by…
- Trial name
- NOAHS-ARC (NCT04864067)
- Testing
- Oxaliplatin, 5-Fluoracil, Leucovorin
- Where
- 3 sites in Chile
- Volunteers
- 39 people
- Sponsor
- Servicio de Salud Metropolitano Sur Oriente
Metastatic Pancreatic Cancer
Post Marketing Surveillance Study for ONIVYDE® in South Korea
The purpose of this study is to characterize the safety of ONIVYDE when used under standard clinical practice in South Korea; and to describe effectiveness in patients receiving ONIVYDE in combination with 5-fluorouracil (5-FU)…
- Trial name
- NCT03446872
- Testing
- ONIVYDE, 5-fluorouracil, Leucovorin
- Where
- 10 sites in South Korea
- Volunteers
- 94 people
- Sponsor
- Institut de Recherches Internationales Servier
Pancreatic Cancer
A Phase 2 Study of LY2495655 in Participants With Pancreatic Cancer
This phase 2 study is a multicenter, randomized, double-blind, placebo-controlled trial in participants with locally advanced/inoperable or metastatic pancreatic cancer, and will investigate 2 different doses of LY2495655 in…
- Trial name
- NCT01505530
- Testing
- LY2495655, Standard of Care Chemotherapy
- Where
- 21 sites in United States, Canada and 3 more
- Volunteers
- 125 people
- Sponsor
- Eli Lilly and Company
Actinic Keratoses
Carac & PDT Combination in the Treatment Of Actinic Keratoses
To demonstrate if Carac treatment after PDT treatment of actinic keratoses leads to superior clinical improvement when compared to Carac or PDT treatment alone. This will be done by manual counts and through photography.
- Trial name
- NCT06712381
- Testing
- Fluorouracil, Photodynamic therapy, Carac in combination with PDT
- Volunteers
- 60 people, healthy volunteers welcome
- Sponsor
- Skin Laser & Surgery Specialists
Carcinoma, Basal Cell, Carcinoma, Squamous Cell
CSP #562 - The VA Keratinocyte Carcinoma Chemoprevention Trial
The main purpose of this study is to see if 5-fluorouracil (5-FU) skin cream can prevent the growth of new skin cancers on the face and ears.
- Conditions
- Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Skin Neoplasms, Skin Diseases
- Trial name
- VAKCCT (NCT00847912)
- Testing
- 5-fluorouracil
- Where
- 13 sites in United States
- Volunteers
- 954 people
- Sponsor
- VA Office of Research and Development
Operable T2-3N+M0 Rectal Cancer (Stage III)
A Study on the Timing of FOLFOX for Patients With Operable, Node Positive Rectal Cancer
This study is proposed to evaluate whether giving part of the chemotherapy prior to radiotherapy and surgery (as opposed to standard of care, which involves giving all the chemotherapy after radiotherapy and surgery) for patients…
- Trial name
- NCT01274962
- Testing
- FOLFOX, high dose rate endorectal brachytherapy
- Where
- 8 sites in Canada
- Volunteers
- 180 people
- Sponsor
- Sir Mortimer B. Davis - Jewish General Hospital
Immune-related Adverse Event, Chemotherapeutic Toxicity
Efficacy and Safety of Neoadjuvant Nivolumab Plus SOX Versus Nivolumab Plus FLOT in Patients With HER2-negative Gastric and Gastroesophageal Junction Adenocarcinoma
The goal of the study is to learn about Safety and efficacy of preoperative adjuvant SOX regimen combined with nivolumab versus FLOT Regimen with nivolumab in HER2-negative Gastric or Gastroesophageal Junction Adenocarcinoma.
- Conditions
- Immune-related Adverse Event, Chemotherapeutic Toxicity, Gastric or Gastroesophageal Junction Adenocarcinoma
- Trial name
- NCT06440811
- Where
- 3 sites in China
- Volunteers
- 120 people
- Sponsor
- Xijing Hospital
Gastro-Intestinal Cancer
Combination of Brivanib With 5-Fluorouracil/Leucovorin (5FU/LV) and 5-Fluorouracil/Leucovorin/Irinotecan (FOLFIRI)
The purpose of this study is to determine a safe and maximum tolerable dose of Brivanib when combined with standard dose 5FU/LV and FOLFIRI.
- Trial name
- NCT01046864
- Testing
- 5-FU, Leucovorin, Irinotecan
- Where
- 6 sites in United States, Canada and 1 more
- Volunteers
- 49 people
- Sponsor
- Bristol-Myers Squibb
Colon Cancer, Colorectal Cancer
Panitumumab Regimen Evaluation in Colorectal Cancer to Estimate Primary Response to Treatment
The primary objective is to estimate the effect of the human homolog of the Kirsten rat sarcoma-2 virus oncogene (KRAS) mutation status (wild type versus mutant) from tumor tissue on efficacy endpoints in patients with metastatic…
- Conditions
- Colon Cancer, Colorectal Cancer, Rectal Cancer, Cancer
- Trial name
- PRECEPT (NCT00411450)
- Testing
- Panitumumab, FOLFIRI
- Volunteers
- 116 people
- Sponsor
- Amgen
Advanced Colorectal Carcinoma
Phase I FOLFOX Combination
A Phase I,open label study to assess the safety and tolerability of ZD6474 in combination with 5-Fluorouracil, Leucovorin and Oxaliplatin (mFOLFOX6) as first and second line therapy in patients with advanced colorectal…
- Trial name
- NCT00499850
- Testing
- ZD6474 (vandetanib), 5-Fluorouracil, Leucovorin
- Where
- 4 sites in Australia
- Volunteers
- 18 people
- Sponsor
- Genzyme, a Sanofi Company
Pancreatic Cancer
Study of Nanoliposomal Irinotecan (Nal-IRI)-Containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma
This is an open-label, phase 2 non-comparative study to assess the safety, tolerability, and preliminary efficacy of nal-IRI in combination with other anticancer therapies in patients not previously treated for metastatic…
- Trial name
- NCT02551991
- Testing
- nal-IRI, 5 fluorouracil, Leucovorin
- Where
- 36 sites in United States, Australia and 1 more
- Volunteers
- 56 people
- Sponsor
- Ipsen
Esophageal Cancer
Fluorouracil, Cisplatin, Cetuximab, and Radiation Therapy in Treating Patients With Esophageal Cancer That Can Be Removed by Surgery
RATIONALE: Drugs used in chemotherapy, such as fluorouracil and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.
- Trial name
- NCT00544362
- Testing
- cetuximab, cisplatin, fluorouracil
- Where
- 13 sites in France
- Volunteers
- 33 people
- Sponsor
- Federation Francophone de Cancerologie Digestive
Lymphoma, Unspecified Adult Solid Tumor, Protocol Specific
Combination Chemotherapy in Treating Patients With Advanced Cancer
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells.
- Trial name
- NCT00003956
- Testing
- fluorouracil, leucovorin calcium, lonafarnib
- Where
- United States
- Volunteers
- 25 people
- Sponsor
- Memorial Sloan Kettering Cancer Center
Colorectal Cancer
A Study of Bevacizumab and Modified FOLFOX-6 (mFOLFOX-6) in Participants With Metastatic Colorectal Cancer
The multicenter, open-label, single-arm, non-randomized, two-stage Simon's design, phase II study (The CLMO-001 Trial) will evaluate the efficacy and safety of bevacizumab in combination with mFOLFOX-6 (Levofolinic acid…
- Trial name
- NCT01383707
- Testing
- 5-Fluorouracil (5-FU), Bevacizumab, Levofolinic acid
- Where
- 11 sites in Italy
- Volunteers
- 77 people
- Sponsor
- Hoffmann-La Roche
Colorectal Cancer
FOLFOXIRI Plus Panitumumab Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only
In this Phase II study the investigators plan to determine the overall response rate (ORR) of the combination of FOLFOXIRI plus panitumumab as first-line treatment of patients with liver-only metastatic KRAS wild-type colorectal…
- Trial name
- NCT01226719
- Testing
- Panitumumab, Oxaliplatin, Irinotecan
- Where
- 15 sites in United States
- Volunteers
- 15 people
- Sponsor
- SCRI Development Innovations, LLC
Esophageal Cancer, Gastric Cancer
FOLFOX +/- Ziv-Aflibercept for Esophageal and Gastric Cancer
Anti-angiogenic therapy is a proven therapeutic target in refractory gastric and gastroesophageal junction adenocarcinoma. This trial assessed whether the addition of a high affinity angiogenesis inhibitor, ziv-aflibercept, could…
- Trial name
- NCT01747551
- Testing
- Oxaliplatin, Leucovorin, Fluorouracil
- Where
- 2 sites in United States
- Volunteers
- 64 people
- Sponsor
- Dana-Farber Cancer Institute
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.